ZAZZI MAURIZIO | Elenco docenti

Rossi, S., Deidda, G., Fiaschi, L., Ibba, R., Pieroni, M., Dichiara, M., et al. (2025). Synthesis and biological investigation of peptidomimetic SARS‐CoV‐2 main protease inhibitors bearing quinoline‐based heterocycles at P3. ARCHIV DER PHARMAZIE, 358(1) [10.1002/ardp.202400812]. - dettaglio
Pacetti, M., Pismataro, M.C., Felicetti, T., Giammarino, F., Bonomini, A., Tiecco, M., et al. (2024). Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5-a]pyrimidines. ORGANIC & BIOMOLECULAR CHEMISTRY, 22(4), 767-783 [10.1039/d3ob01861j]. - dettaglio
Di Teodoro, G., Pirkl, M., Incardona, F., Vicenti, I., Sönnerborg, A., Kaiser, R., et al. (2024). Incorporating temporal dynamics of mutations to enhance the prediction capability of antiretroviral therapy’s outcome for HIV-1. BIOINFORMATICS, 40(6) [10.1093/bioinformatics/btae327]. - dettaglio
Ripamonti, D., Rusconi, S., Zazzi, M. (2024). A cautionary note on entry and exit strategies with long-acting cabotegravir and rilpivirine. AIDS, 38(2), 263-265 [10.1097/QAD.0000000000003760]. - dettaglio
Clemente, T., Galli, L., Lolatto, R., Gagliardini, R., Lagi, F., Ferrara, M., et al. (2024). Cohort profile: PRESTIGIO, an Italian prospective registry-based cohort of people with HIV-1 resistant to reverse transcriptase, protease and integrase inhibitors. BMJ OPEN, 14(2) [10.1136/bmjopen-2023-080606]. - dettaglio